NCT00029159View on ClinicalTrials.gov

The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 1992

Primary Completion Date

January 31, 2007

Study Completion Date

June 30, 2012

Conditions

Turner Syndrome

Interventions

DRUG

estrogen

Participants were started on ethinyl estradiol at a daily dose of 50ng/kg at the beginning of the 3rd year of the study. The estrogen was continued until study end.

DRUG

androgen

Oxandrolone or placebo capsule, .06mg/kg/day, orally, for 2 years

OTHER

placebo

an inactive substance

Trial Locations (2)

19102

Thomas Jefferson University Hospital, 1025 Walnut Street, Suite 726, Philadelphia

20892

National Institutes of Health, Bethesda

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Thomas Jefferson University

OTHER

NCT00029159 - The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome | Biotech Hunter | Biotech Hunter